TiGenix The Latest Partner In Takeda Deal Frenzy
This article was originally published in PharmAsia News
Executive Summary
The latest in a non-stop succession of deals over the past few weeks for Takeda sees the Japanese major add a late-stage TiGenix asset to its GI care portfolio, with Europe to be the initial focus of the tie-up.